Please ensure Javascript is enabled for purposes of website accessibility

Welcome to Regulatory Rapporteur. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
topra-logo

The Organisation for Professionals in Regulatory Affairs

Site name
Mast navigation
  • Become a member
  • Sign in
Search our site
Menu
Close menu
  • Regulatory Rapporteur - June 2025
  • Pharmaceuticals
    • Back to parent navigation item
    • Pharmaceuticals
    • Artificial intelligence
    • ATMP
    • Biologics
    • Chemistry, manufacturing and controls
    • Clinical trials
    • Non-clinical development
    • Oncology
    • Product information
    • Regulatory procedures
  • Veterinary
  • Medical devices
    • Back to parent navigation item
    • Medical devices
    • Combination products
    • In-vitro diagnostics
    • Software
    • Artificial intelligence
  • Industry news
    • Back to parent navigation item
    • Industry news
    • Industry news
      • Back to parent navigation item
      • Industry news
      • Read latest news
      • Video
  • Commentary
    • Back to parent navigation item
    • Commentary
    • Editorials
    • Letters to the Editor
    • Podcasts
  • Collections
    • Back to parent navigation item
    • Collections
    • Interviews
    • Symposium 2024
      • Back to parent navigation item
      • Symposium 2024
      • Annual lecture
    • Symposium 2023
      • Back to parent navigation item
      • Symposium 2023
      • Annual lecture
    • Symposium 2022
      • Back to parent navigation item
      • Symposium 2022
      • Annual lecture
    • Symposium 2021
      • Back to parent navigation item
      • Symposium 2021
      • Annual lecture
    • CPD supplements
      • Back to parent navigation item
      • CPD supplements
      • 2021/2022
      • 2020
      • 2019
  • JOIN TOPRA
  • topra-logo

    The Organisation for Professionals in Regulatory Affairs

  • Regulatory Rapporteur - June 2025
  • Pharmaceuticals
      • Artificial intelligence
      • ATMP
      • Biologics
      • Chemistry, manufacturing and controls
      • Clinical trials
      • Non-clinical development
      • Oncology
      • Product information
      • Regulatory procedures
    • FDAPLAT final
      ​Navigating the FDA’s platform technology designation: Key insights and best practices for drug manufacturers
    • ODD licensed image
      Navigating orphan drug designation in the EU
    • AIFORPV_final image
      Prescribing efficiency: Using generative artificial intelligence for pharmacovigilance
  • Veterinary
    • RR-June-2025-half cover _masthead
      June 2025 – Contents
    • June cover image licensed
      Veterinary medicines: Translating regulation into practice
    • RR-Nov-2024-Half-Cover
      November 2024 – Contents: Veterinary medicines sessions
    • SUSIMPERATIVE_compressed
      The sustainability imperative for the healthcare sector
  • Medical devices
      • Combination products
      • In-vitro diagnostics
      • Software
      • Artificial intelligence
    • MDR-innovation-compressed
      The EU Medical Device Regulation: Balancing innovation with regulation
    • final licensed cover image_compressed
      Medical device regulation: Challenges, innovation and the future
    • RR-Nov-2024-Half-Cover
      November 2024 – Contents: Medical devices/IVDs sessions
  • Industry news
      • Industry news
        • Read latest news
        • Video
    • animal test news licensed image
      ​FDA to replace animal testing with new approach methodologies
    • EMA VMR news licensed image
      EMA to address antimicrobial resistance risks from veterinary medicinal products
    • AdobeStock_232436477
      ​MHRA authorises new cancer treatment variation with significantly reduced administration time
  • Commentary
      • Editorials
      • Letters to the Editor
      • Podcasts
    • June cover image licensed
      Veterinary medicines: Translating regulation into practice
    • 6. cover image idea 6
      Advanced therapies: A maturing regulatory framework
    • TOPRA VetReg Podcast 800x533px (6.4 ratio)
      RegRapPod − InConversation with Ivo Claassen
  • Collections
      • Interviews
      • Symposium 2024
        • Annual lecture
      • Symposium 2023
        • Annual lecture
      • Symposium 2022
        • Annual lecture
      • Symposium 2021
        • Annual lecture
      • CPD supplements
        • 2021/2022
        • 2020
        • 2019
    • Banner_new
      Streamline medical device compliance with BSI Compliance NavigatorSponsored by The UK's National Standards Body
    • AdobeStock_59790119
      The Olaratumab experience
    • AdobeStock_207448226
      Qualification of stride velocity endpoint in Duchenne Muscular Dystrophy
  • JOIN TOPRA
  • More from navigation items

Search results

Your search for "World Health Organization (WHO)" OR WHO found 53 results. Displaying results 1 to 10 | Search Help

Use the filters to refine the results. Or use quotation marks to search for an exact phrase - e.g. "pocket money". Or use NOT to reduce unwanted matches, e.g. Paris NOT Texas, will find matches for Paris, but exclude stories which also have the word Texas.
Filter search

Filters

Keyword

Filter your search

By Type

No selections available

By Regulatory Area

No selections available

By Location

No selections available

By Topics

No selections available

By date

No selections available
  • Date range
  • Save article
    Please Sign in to your account to use this feature
    WHO Pandemic Agreement gains signatories
    Industry news

    WHO Pandemic Agreement gains signatories

    2024-10-23T14:40:00Z

    The President of UNITE signs statement in support of the World Health Organization (WHO) Pandemic Agreement

  • Save article
    Please Sign in to your account to use this feature
    WHO issues warning on fake opioids in Europe
    Industry news

    WHO issues warning on fake opioids in Europe

    2024-09-16T09:22:00Z

    The World Health Organization (WHO) has issued an alert that falsified Oxymorphone Hydrochloride has been detected in Finland.

  • Save article
    Please Sign in to your account to use this feature
    Unique aspects of biologic reference standards
    Journal

    Unique aspects of biologic reference standards

    2025-01-10T08:50:00Z

    Reference standards are pivotal in ensuring pharmaceutical quality, especially for complex biologics. This article reviews definitions and classifications of reference standards as outlined by the US Food and Drug Administration (FDA), the World Health Organization (WHO) and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Q6B and Q7 guidelines. It addresses types of standards based on source and use, with particular emphasis on the distinct requirements for biologics.

  • Save article
    Please Sign in to your account to use this feature
    Cholera vaccine shortage puts millions at risk
    Industry news

    Cholera vaccine shortage puts millions at risk

    2024-04-03T11:04:00Z

    The World Health Organization  has declared a worldwide shortage of the oral cholera vaccine amid an upsurge in cases.

  • Save article
    Please Sign in to your account to use this feature
    WHO endorses use of R21/Matrix-M malaria vaccine in children
    Industry news

    WHO endorses use of R21/Matrix-M malaria vaccine in children

    2023-10-31T12:29:00Z

    The World Health Organization (WHO) has recommended widespread use of the R21/Matrix-M malaria vaccine in children.

  • Save article
    Please Sign in to your account to use this feature
    The global access battle for healthcare equity
    Editorial

    The global access battle for healthcare equity

    2024-06-11T15:30:00Z

    Regulatory Rapporteur June 2024 | Volume 21 | No.6 The World Health Organization (WHO) has estimated that one-third of the global population lacks regular access to essential medicines. The concept of access to medicines will likely resonate differently within ...

  • Save article
    Please Sign in to your account to use this feature
    Divergence on the definition of regulatory reliance in international regions: Is there room for convergence?
    Journal

    Divergence on the definition of regulatory reliance in international regions: Is there room for convergence?

    2025-06-06T14:08:00Z

    The article explores how reliance pathways can be used for MAAs and incorporates AstraZeneca’s research findings on this topic.

  • Save article
    Please Sign in to your account to use this feature
    Key milestone reached in African medicines regulation
    Industry news

    Key milestone reached in African medicines regulation

    2025-04-07T09:02:00Z

    A key milestone for medicines regulation in Africa has been reached with the first continental listing of five medicinal products by the African Medicines Regulatory Harmonisation (AMRH) Steering Committee.

  • Save article
    Please Sign in to your account to use this feature
    ​Gene Therapy Medicinal Products: An examination of regulatory CMC requirements
    Journal

    ​Gene Therapy Medicinal Products: An examination of regulatory CMC requirements

    2025-05-01T09:43:00Z

    This article explores the CMC requirements for GTMPs to help ensure high quality and safe products are brought to market.

  • Save article
    Please Sign in to your account to use this feature
    VM1: Advancing regulatory policies for One Health – A holistic approach to animal and public health
    Journal

    VM1: Advancing regulatory policies for One Health – A holistic approach to animal and public health

    2024-11-08T06:57:00Z

     

  • Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next Page
  • What is Regulatory Affairs?
  • TOPRA Membership
  • Regulatory Rapporteur Editorial Board
  • Regulatory Rapporteur Editorial Area
  • Future Focus Topics
  • FAQs
  • Glossary
  • Privacy Policy
  • ISSN 2755-5070 (online)

    ISSN 1742-8955 (print - legacy)

Regulatory Rapporteur

The peer-reviewed journal, published 11 times per year and available free to TOPRA members.

Follow TOPRA
topra-logo

The Organisation for Professionals in Regulatory Affairs

TOPRA office
TOPRA Publishing, Third floor, City Reach, 5 Greenwich View Place, London E14 9NN, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org

TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70

  • Contact us
  • Copyright © 2015-2025 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved

Site powered by Webvision Cloud